Complement activation and rituximab distribution in CNS NHL--letter

Clin Cancer Res. 2015 Jan 15;21(2):490. doi: 10.1158/1078-0432.CCR-14-0939.

Authors

Silvia Hofer¹, Karin Mengele², Manfred Schmitt², Bernhard Pestalozzi³, Stefan Aebi⁴

Affiliations

¹ Department of Oncology, University Hospital Zurich, Zurich, Switzerland. Division of Medical Oncology, Kantonsspital Luzern, Luzern, Switzerland. silvia.hofer@luks.ch.
² Clinical Research Unit, Department of Obstetrics and Gynecology, Technische Universität Munich, Munich, Germany.
³ Department of Oncology, University Hospital Zurich, Zurich, Switzerland.
⁴ Division of Medical Oncology, Kantonsspital Luzern, Luzern, Switzerland.

PMID: 25593346
DOI: 10.1158/1078-0432.CCR-14-0939

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal, Murine-Derived / pharmacokinetics*
Antineoplastic Agents / pharmacokinetics*
Central Nervous System Neoplasms / cerebrospinal fluid*
Complement Activation*
Female
Humans
Lymphoma / cerebrospinal fluid*
Male
Neoplasm Recurrence, Local / cerebrospinal fluid*

Substances

Antibodies, Monoclonal, Murine-Derived
Antineoplastic Agents